SMS Pharmaceuticals Statistics

Total Valuation

BOM:532815 has a market cap or net worth of INR 22.54 billion. The enterprise value is 25.23 billion.

Market Cap	22.54B
Enterprise Value	25.23B

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	Sep 23, 2024

Share Statistics

Current Share Class	88.65M
Shares Outstanding	n/a
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	45.35M

Valuation Ratios

The trailing PE ratio is 32.60.

PE Ratio	32.60
Forward PE	n/a
PS Ratio	2.86
PB Ratio	3.52
P/TBV Ratio	3.53
P/FCF Ratio	n/a
P/OCF Ratio	27.58
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.17, with an EV/FCF ratio of -60.54.

EV / Earnings	36.49
EV / Sales	3.20
EV / EBITDA	17.17
EV / EBIT	22.40
EV / FCF	-60.54

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.49.

Current Ratio	1.71
Quick Ratio	0.76
Debt / Equity	0.49
Debt / EBITDA	2.14
Debt / FCF	-7.46
Interest Coverage	5.98

Financial Efficiency

Return on equity (ROE) is 11.76% and return on invested capital (ROIC) is 7.84%.

Return on Equity (ROE)	11.76%
Return on Assets (ROA)	6.34%
Return on Invested Capital (ROIC)	7.84%
Return on Capital Employed (ROCE)	13.39%
Revenue Per Employee	6.59M
Profits Per Employee	577,574
Employee Count	1,197
Asset Turnover	0.72
Inventory Turnover	2.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+34.65%
50-Day Moving Average	236.85
200-Day Moving Average	260.75
Relative Strength Index (RSI)	51.58
Average Volume (20 Days)	11,898

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532815 had revenue of INR 7.89 billion and earned 691.36 million in profits. Earnings per share was 8.16.

Revenue	7.89B
Gross Profit	2.66B
Operating Income	1.11B
Pretax Income	940.74M
Net Income	691.36M
EBITDA	1.45B
EBIT	1.11B
Earnings Per Share (EPS)	8.16

Full Income Statement

Balance Sheet

The company has 415.86 million in cash and 3.11 billion in debt, giving a net cash position of -2.69 billion.

Cash & Cash Equivalents	415.86M
Total Debt	3.11B
Net Cash	-2.69B
Net Cash Per Share	n/a
Equity (Book Value)	6.40B
Book Value Per Share	75.57
Working Capital	2.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 817.09 million and capital expenditures -1.23 billion, giving a free cash flow of -416.71 million.

Operating Cash Flow	817.09M
Capital Expenditures	-1.23B
Free Cash Flow	-416.71M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 33.66%, with operating and profit margins of 14.05% and 8.76%.

Gross Margin	33.66%
Operating Margin	14.05%
Pretax Margin	11.92%
Profit Margin	8.76%
EBITDA Margin	18.41%
EBIT Margin	14.05%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.15%.

Dividend Per Share	0.40
Dividend Yield	0.15%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	1
Payout Ratio	4.90%
Buyback Yield	-0.09%
Shareholder Yield	0.07%
Earnings Yield	3.07%
FCF Yield	-1.85%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.

Last Split Date	Dec 17, 2015
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a